Cargando…

Safety of a New Synbiotic Starter Formula

PURPOSE: Breastfeeding is the best way to feed all infants, but not all infants can be (exclusively) breastfed. Cow's milk based infant formula is the second choice infant feeding. METHODS: The safety of a new synbiotic infant formula, supplemented with Bifidobacterium lactis and fructo-oligosa...

Descripción completa

Detalles Bibliográficos
Autores principales: Vandenplas, Yvan, Analitis, Antonis, Tziouvara, Chara, Kountzoglou, Athina, Drakou, Anastasia, Tsouvalas, Manos, Mavroudi, Antigoni, Xinias, Ioannis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5636933/
https://www.ncbi.nlm.nih.gov/pubmed/29026733
http://dx.doi.org/10.5223/pghn.2017.20.3.167
_version_ 1783270540923895808
author Vandenplas, Yvan
Analitis, Antonis
Tziouvara, Chara
Kountzoglou, Athina
Drakou, Anastasia
Tsouvalas, Manos
Mavroudi, Antigoni
Xinias, Ioannis
author_facet Vandenplas, Yvan
Analitis, Antonis
Tziouvara, Chara
Kountzoglou, Athina
Drakou, Anastasia
Tsouvalas, Manos
Mavroudi, Antigoni
Xinias, Ioannis
author_sort Vandenplas, Yvan
collection PubMed
description PURPOSE: Breastfeeding is the best way to feed all infants, but not all infants can be (exclusively) breastfed. Cow's milk based infant formula is the second choice infant feeding. METHODS: The safety of a new synbiotic infant formula, supplemented with Bifidobacterium lactis and fructo-oligosaccharides, with lactose and a whey/casein 60/40 protein ratio was tested in 280 infants during 3 months. RESULTS: The median age of the infants at inclusion was 0.89 months. Weight evolution was in accordance with the World Health Organization growth charts for exclusive breastfed infants. The evolution of all anthropometric parameters (weight-for-length z score and body mass index-for-age z score) was within the normal range. The incidence of functional constipation (3.2%), daily regurgitation (10.9%), infantile crying and colic (10.5%) were all significantly lower than the reported median prevalence for a similar age according to literature (median value of 7.8% for functional constipation, 26.7% for regurgitation, 17.7% for infantile colic). CONCLUSION: The new synbiotic infant starter formula was safe, resulted in normal growth and was well tolerated. Functional gastro-intestinal manifestations (functional constipation, regurgitation and colic) were significantly lower than reported in literature. Synbiotics (Bifidobacterium lactis and fructo-oligosaccharides) in cow's milk based infant formula bring the second choice infant feeding, formula, closer to the golden standard, exclusive breastfeeding.
format Online
Article
Text
id pubmed-5636933
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition
record_format MEDLINE/PubMed
spelling pubmed-56369332017-10-12 Safety of a New Synbiotic Starter Formula Vandenplas, Yvan Analitis, Antonis Tziouvara, Chara Kountzoglou, Athina Drakou, Anastasia Tsouvalas, Manos Mavroudi, Antigoni Xinias, Ioannis Pediatr Gastroenterol Hepatol Nutr Original Article PURPOSE: Breastfeeding is the best way to feed all infants, but not all infants can be (exclusively) breastfed. Cow's milk based infant formula is the second choice infant feeding. METHODS: The safety of a new synbiotic infant formula, supplemented with Bifidobacterium lactis and fructo-oligosaccharides, with lactose and a whey/casein 60/40 protein ratio was tested in 280 infants during 3 months. RESULTS: The median age of the infants at inclusion was 0.89 months. Weight evolution was in accordance with the World Health Organization growth charts for exclusive breastfed infants. The evolution of all anthropometric parameters (weight-for-length z score and body mass index-for-age z score) was within the normal range. The incidence of functional constipation (3.2%), daily regurgitation (10.9%), infantile crying and colic (10.5%) were all significantly lower than the reported median prevalence for a similar age according to literature (median value of 7.8% for functional constipation, 26.7% for regurgitation, 17.7% for infantile colic). CONCLUSION: The new synbiotic infant starter formula was safe, resulted in normal growth and was well tolerated. Functional gastro-intestinal manifestations (functional constipation, regurgitation and colic) were significantly lower than reported in literature. Synbiotics (Bifidobacterium lactis and fructo-oligosaccharides) in cow's milk based infant formula bring the second choice infant feeding, formula, closer to the golden standard, exclusive breastfeeding. The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition 2017-09 2017-09-26 /pmc/articles/PMC5636933/ /pubmed/29026733 http://dx.doi.org/10.5223/pghn.2017.20.3.167 Text en Copyright © 2017 by The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition http://creativecommons.org/licenses/by-nc/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Vandenplas, Yvan
Analitis, Antonis
Tziouvara, Chara
Kountzoglou, Athina
Drakou, Anastasia
Tsouvalas, Manos
Mavroudi, Antigoni
Xinias, Ioannis
Safety of a New Synbiotic Starter Formula
title Safety of a New Synbiotic Starter Formula
title_full Safety of a New Synbiotic Starter Formula
title_fullStr Safety of a New Synbiotic Starter Formula
title_full_unstemmed Safety of a New Synbiotic Starter Formula
title_short Safety of a New Synbiotic Starter Formula
title_sort safety of a new synbiotic starter formula
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5636933/
https://www.ncbi.nlm.nih.gov/pubmed/29026733
http://dx.doi.org/10.5223/pghn.2017.20.3.167
work_keys_str_mv AT vandenplasyvan safetyofanewsynbioticstarterformula
AT analitisantonis safetyofanewsynbioticstarterformula
AT tziouvarachara safetyofanewsynbioticstarterformula
AT kountzoglouathina safetyofanewsynbioticstarterformula
AT drakouanastasia safetyofanewsynbioticstarterformula
AT tsouvalasmanos safetyofanewsynbioticstarterformula
AT mavroudiantigoni safetyofanewsynbioticstarterformula
AT xiniasioannis safetyofanewsynbioticstarterformula